Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  PAREXEL International Corporation    PRXL

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. engages in the provision of clinical research, medical communications, consulting, commercialization and informatics, and technology services to pharmaceutical, biotechnology, and medical device industries.

It operates through the following segments: Clinical Research Services, PAREXEL Consulting Services and PAREXEL Informatics.

The Clinical Research Services segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, date management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, clinical pharmacology, and related medical affairs, patient recruitment and investigator site services.

The PAREXEL Consulting Services segment provides technical expertise and advice in drug development, regulatory affairs, and good manufacturing practice compliance consulting.

The PAREXEL Informatics segment provides information technology solutions designed to improve client's product development processes.

The company was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.

Number of employees : 18 600 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Clinical Research Services1,53565.8%1,62667% +5.9%
PAREXEL Informatics264.6711.3%277.9011.4% +5%
PAREXEL Consulting Services215.959.3%190.407.8% -11.83%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States984.6842.2%908.9037.4% -7.7%
Europe, Middle East & Africa451.4619.4%568.1023.4% +25.84%
Asia/Pacific269.3011.5%296.7012.2% +10.18%
United Kingdom239.6510.3%251.0010.3% +4.74%
Americas70.903%69.602.9% -1.83%
Managers
NameAgeSinceTitle
Josef H. von Rickenbach, MBA621983Chairman & Chief Executive Officer
Mark A. Goldberg, MD561997President & Chief Operating Officer
Emma Reeve562014CFO, Principal Accounting Officer, VP & Controller
Sy Pretorius MD, MBA--Chief Scientific Officer & Vice President
A. Dana Callow Jr., MBA651986Independent Director
Patrick J. Fortune PhD, MBA701996Independent Director
Richard L. Love732002Independent Director
Ellen M. Zane652006Independent Director
Christopher J. Lindop, CPA582006Independent Director
Eduard Enrico Holdener, MD712008Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 53,267,019 52,260,760 98.1% 0 0.0% 98.1%
Shareholders
NameEquities%
BlackRock Fund Advisors 4,623,668 8.68%
The Vanguard Group, Inc. 4,495,778 8.44%
UBS Financial Services, Inc. 3,103,215 5.83%
Fisher Asset Management LLC 2,244,444 4.21%
SSgA Funds Management, Inc. 1,681,773 3.16%
Wellington Management Co. LLP 1,671,513 3.14%
Neuberger Berman Investment Advisers LLC 1,353,313 2.54%
Frontier Capital Management Co. LLC 1,196,943 2.25%
Aberdeen Asset Managers Ltd. 1,113,671 2.09%
Northern Trust Investments, Inc. 990,625 1.86%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
PAREXEL INTERNATIONAL ..6.74%3 737
INCYTE CORPORATION16.90%22 083
QUINTILES IMS HOLDINGS..0.07%18 734
CELLTRION, INC.--.--%10 483
LONZA GROUP AG4.03%9 679
ALKERMES PLC0.72%8 507
SEATTLE GENETICS, INC.11.41%8 322
QIAGEN NV-1.36%6 626
UNITED THERAPEUTICS CO..6.39%6 473
IONIS PHARMACEUTICALS ..-1.80%5 693
ICON PLC6.48%4 489
CHARLES RIVER LABORATO..4.82%3 780
ACADIA PHARMACEUTICALS..7.56%3 757
BIO-TECHNE CORP-4.68%3 657
PRA HEALTH SCIENCES IN..0.13%3 389
ALNYLAM PHARMACEUTICAL..4.06%3 343
GALAPAGOS2.58%3 094
INTREXON CORP-4.07%2 764
INC RESEARCH HOLDINGS ..-4.75%2 686
IRONWOOD PHARMACEUTICA..-3.40%2 160
LIGAND PHARMACEUTICALS..1.55%2 156
Sector Biotechnology & Medical Research - NEC
PAREXEL International Corp : Connections
Applied Microarrays, Inc.
Harvard T.H. Chan School of Public Health
MedAptus, Inc.
Molecular Profiling Institute, Inc.
Tufts University
Jobs for Massachusetts, Inc.
Cancer Prevention Pharmaceuticals Inc
PHT Technologies, Inc.
Caris Molecular Profiling Institute, Inc.
The Leukemia & Lymphoma Society, Inc.
TVP Management Co. LLC
The Floating Hospital, Inc.
Center For Private Equity & Entrepreneurship
Boston Millennia Partners III LP
George Washington University
Tufts University School of Medicine
New England Healthcare Institute
CardioMEMS, Inc.
MedTrust Online LLC
Epigenesis Pharmaceuticals LLC
Ascalon International, Inc.
Sapphire Therapeutics, Inc.
Syndevrx, Inc.
University of Wisconsin Foundation
PMed Management LLC
University of Illinois
Translational Accelerator LLC
Sun Mountain Capital LLC
Minuteman Health, Inc.
Cleveland Clinic Innovations
Global Med Technologies, Inc.
Press Ganey Associates, Inc.
PAREXEL International Ltd.
Agnovos Healthcare LLC
Ascalon Pharmaceuticals
CerRx, Inc.
Swiss Cancer Foundation
Company contact information
PAREXEL International Corp.
195 West Street
Waltham, MA 02451

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
© 2017 People , Fundamentals and Ownership